Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin versus amoxicillin + metronidazole versus placebo with scaling and root planing for chronic periodontitis
ACTRN12615001047583Phase 2Active, not recruiting
- Sponsor
- Meredith Owen
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of azithromycin, amoxicillin and metronidazole in chronic periodontitis (3 arms), sponsored by Meredith Owen. Primary endpoints: Reduction in probing pocket depths and Reduction in bacterial counts. Started Sep 2016; status: active, not recruiting.
02
Drugs
azithromycinamoxicillinmetronidazole
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on ACTRN12615001047583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001047583.